United Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.08.24	Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug (RTTNews)
03.06.24	Liquidia Says Court Denies United Therapeutics' Motion For Injunction To Block Launch Of YUTREPIA (RTTNews)
25.03.24	United Therapeutics To Repurchase Up To $1 Bln Shares (RTTNews)
21.02.24	United Therapeutics Q4 Net Income Rises (RTTNews)
02.01.24	MannKind Corp.: Sagard Healthcare Purchases 1% Royalty In Tyvaso DPI Net Sales (RTTNews)
30.10.23	United Therapeutics To Acquire Miromatrix - Quick Facts (RTTNews)
01.09.22	United Therapeutics Says Prevails In Dry Powder Inhaler Patent Litigation (RTTNews)
24.05.22	United Therapeutics Says Tyvaso DPI Gets FDA Approval (RTTNews)
03.11.21	United Therapeutics Corporation Reports Third Quarter 2021 Financial Results (PR Newswire)
01.11.21	United Therapeutics Corporation To Present At The Credit Suisse 30th Annual Healthcare Conference (PR Newswire)
27.10.21	United Therapeutics Corporation To Report Third Quarter 2021 Financial Results Before The Market Opens On Wednesday, November 3, 2021 (PR Newswire)
21.10.21	United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021 (PR Newswire)
18.10.21	United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application (PR Newswire)
11.10.21	United Therapeutics to Present New Data at CHEST Annual Meeting 2021 (PR Newswire)
30.09.21	United Therapeutics Converts to a Public Benefit Corporation Following Shareholder Approval (PR Newswire)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
10.09.21	United Therapeutics Releases its Annual Corporate Responsibility Report (PR Newswire)
07.09.21	United Therapeutics Presents Tyvaso DPI™ BREEZE Clinical Data At The European Respiratory Society International Congress 2021 (PR Newswire)
25.08.21	United Therapeutics Partners with Former NFL Player Devon Still and His Daughter Leah to Launch "Braving NeuroBLASToma" in Honor of Childhood Cancer Awareness Month (PR Newswire)
24.08.21	United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021 (PR Newswire)
04.08.21	United Therapeutics Corporation Reports Second Quarter 2021 Financial Results (PR Newswire)
03.08.21	United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual Conference (PR Newswire)
28.07.21	United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021 (PR Newswire)
30.06.21	United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study (PR Newswire)
16.06.21	MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDA (PR Newswire)
16.06.21	United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review (PR Newswire)
19.04.21	United Therapeutics Files New Drug Application For Tyvaso DPI- Quick Fats (RTTNews)
01.04.21	United Therapeutics: FDA Approves Tyvaso For PH-ILD - Quick Facts (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
04.03.21	KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On Trevyent (RTTNews)
28.12.20	United Therapeutics Plans To Apply Priority Review Voucher To NDA For Tyvaso DPI (RTTNews)
09.12.20	United Therapeutics: Treprostinil Receives Orphan Drug Designation - Quick Facts (RTTNews)
18.08.20	NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr. (RTTNews)
25.02.20	COCP, MRNA Jump On Coronavirus Update, LPCN Making 4th Try, NGM Up On NASH Data (RTTNews)
04.02.20	AVXL On Track, INSM Breathes Easy, UTHR's Small Cell Lung Cancer Trial Fails (RTTNews)
03.02.20	United Therapeutics' Small Cell Lung Cancer Study Primary Endpoint Not Meet (RTTNews)
09.04.19	CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub (RTTNews)
08.04.19	United Therapeutics To Discontinue Further Esuberaprost Development (RTTNews)
05.09.18	MNKD Takes Giant Leap, REPH On Watch, ALRN To Report Study Data In Q4 (RTTNews)
04.09.18	United Therapeutics, MannKind Enter Licensing Agreement For Treprostinil (RTTNews)
09.08.18	FDA Panel Nod For PRTK, INSY Settles With DOJ, Rite Aid Scraps Merger Deal (RTTNews)
12.06.18	United Therapeutics, XVIVO Perfusion To Expand Organ Evaluation Service (RTTNews)
12.06.18	United Therapeutics And XVIVO Perfusion Announce Collaboration To Reduce Organ Shortage Through Expansion Of Organ Evaluation Service (PR Newswire)
02.05.18	United Therapeutics Corporation Reports First Quarter 2018 Financial Results (PR Newswire)
30.04.18	United Therapeutics To Acquire SteadyMed Ltd. (PR Newswire)
24.04.18	United Therapeutics Corporation To Report First Quarter 2018 Financial Results Before The Market Opens On Wednesday, May 2, 2018 (PR Newswire)
20.03.18	Lifshitz & Miller LLP Announces Investigation of Allstate Corporation, Blue Buffalo Pet Products, Inc., Express Scripts Holding Company, Funko, Inc., PHH Corporation, Seven Stars Cloud Group, Inc. (PR Newswire)
14.03.18	United Therapeutics Corporation To Present At Oppenheimer 28th Annual Healthcare Conference (PR Newswire)
07.03.18	United Therapeutics Corporation To Present At Cowen And Company 38th Annual Health Care Conference (PR Newswire)
26.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Corporation (UTHR) (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

18.12.24		Börsianer warten auf Impulse: NASDAQ Composite kaum bewegt
18.12.24		Handel in New York: NASDAQ Composite legt zu
15.11.24		NASDAQ Composite aktuell: NASDAQ Composite mittags mit Abgaben
23.10.24		NASDAQ-Handel NASDAQ Composite gibt nach
28.08.24		Handel in New York: So performt der NASDAQ Composite am Mittwochnachmittag
28.08.24		Schwache Performance in New York: So steht der NASDAQ Composite aktuell
28.08.24		Schwacher Handel: NASDAQ Composite zum Handelsstart schwächer
19.08.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite zum Ende des Montagshandels im Aufwind

18.12.24

Börsianer warten auf Impulse: NASDAQ Composite kaum bewegt

18.12.24

Handel in New York: NASDAQ Composite legt zu

15.11.24

NASDAQ Composite aktuell: NASDAQ Composite mittags mit Abgaben

23.10.24

NASDAQ-Handel NASDAQ Composite gibt nach

28.08.24

Handel in New York: So performt der NASDAQ Composite am Mittwochnachmittag

28.08.24

Schwache Performance in New York: So steht der NASDAQ Composite aktuell